
Sign up to save your podcasts
Or
In this episode of The Upgrade podcast, we discuss Sotera and Parexel; how they have fared in the pandemic and what would be required for an upgrade. We also discuss where they rank in the Top 250 and how their respective debt pricing may be viewed by CLO managers. Guests are analysts from S&P’s U.S. corporate ratings healthcare team and CLO team.
4.8
44 ratings
In this episode of The Upgrade podcast, we discuss Sotera and Parexel; how they have fared in the pandemic and what would be required for an upgrade. We also discuss where they rank in the Top 250 and how their respective debt pricing may be viewed by CLO managers. Guests are analysts from S&P’s U.S. corporate ratings healthcare team and CLO team.
4,346 Listeners
28 Listeners
30 Listeners
6 Listeners
40 Listeners
10 Listeners
11 Listeners
4 Listeners
59 Listeners
30 Listeners
14 Listeners
410 Listeners
17 Listeners
29 Listeners
1 Listeners
6 Listeners
5 Listeners
2 Listeners
20 Listeners
5 Listeners
0 Listeners
5 Listeners
12 Listeners
5 Listeners